Stimulation Index for PCNA mRNA in Peripheral Blood as Immune Function Monitoring After Renal Transplantation-Reference-Cited by-同舟云学术

Stimulation Index for PCNA mRNA in Peripheral Blood as Immune Function Monitoring After Renal Transplantation

Published:2009-05-15 Issue:9 Volume:87 Page:1411-1414
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Niwa Misao,Miwa Yuko,Kuzuya Takafumi,Iwasaki Kenta,Haneda Masataka,Ueki Tsuneo,Katayama Akio,Hiramitsu Takahisa,Goto Norihiko,Nagasaka Takaharu,Watarai Yoshihiko,Uchida Kazuharu,Nakao Akimasa,Kobayashi Takaaki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.;Böhler;Ther Drug Monit,2007

2. Pharmacodynamics of T-cell function for monitoring immunosuppression.;Barten;Cell Prolif,2007

3. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: Potential clinical implications.;Weimert;Ther Drug Monit,2007

4. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.;Sommerer;Transplantation,2006

5. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients.;Koefoed-Nielsen;Transpl Int,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune characteristics of kidney transplant recipients with acute respiratory distress syndrome induced by COVID-19 at single-cell resolution;Respiratory Research;2024-01-18

2. Therapeutic inhibition of galectin‑3 improves cardiomyocyte apoptosis and survival during heart failure;Molecular Medicine Reports;2017-12-20

3. Gene Expression Technology Applied to Kidney Transplantation;Kidney Transplantation, Bioengineering and Regeneration;2017

4. Analytical Aspects of the Implementation of Biomarkers in Clinical Transplantation;Therapeutic Drug Monitoring;2016-04

5. Markers of lymphocyte activation and proliferation;Personalized Immunosuppression in Transplantation;2016